Tricida Inc (NASDAQ:TCDA)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - TCDA

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - TCDA

  • Market Cap$397.390m
  • SymbolNASDAQ:TCDA
  • IndustryHealthcare
  • SectorDrug Manufacturers - Specialty & Generic
  • Currency
  • ISINUS89610F1012

Company Profile

Tricida Inc is a late-stage pharmaceutical company. It is focused on the development and commercialization of its drug candidate, veverimer (TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis by binding and removing acid from the gastrointestinal, or GI, tract. The primary area of focus is to slow the progression of chronic kidney disease through the treatment of metabolic acidosis.Tricida Inc is a late-stage pharmaceutical company. It is engaged in the development of novel therapeutics to address renal, metabolic and cardiovascular disease.

Latest TCDA news

Currently there for this company. Visit our news hub for other news .